NCT01878188View on ClinicalTrials.gov

Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2017

Conditions
Transitional Cell Carcinoma of Bladder
Interventions
DRUG

BC-819/PEI

Intravesical instillation

DRUG

BCG Vaccine

intravesical instillations

Trial Locations (7)

Unknown

Bnai Zion MC, Haifa

Carmel Medical Center, Haifa

Wolfson Medical Center, Holon

Hadassah Ein Karem Medical Center, Jerusalem

Meir MC, Kfar Saba

Tel Aviv Medical Center, Tel Aviv

Assaf Harofe Medical Center, Ẕerifin

Sponsors
All Listed Sponsors
lead

Anchiano Therapeutics Israel Ltd.

INDUSTRY

NCT01878188 - Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma | Biotech Hunter | Biotech Hunter